Toxic shock syndrome in the burned patient

British Journal of Biomedical Science

Volumn 54, Issue 2, 1997, Pages 110-117

  Edwards Jones, Valerie ^a   Shawcross, Susan G ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Burns; Shock, septic; Staphylococcus aureus

Indexed keywords

BURN; HUMAN; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; TOXIC SHOCK SYNDROME;

BURNS; CHILD; ENTEROTOXINS; HUMANS; RISK FACTORS; SHOCK, SEPTIC; STAPHYLOCOCCUS AUREUS;

EID: 0030915144     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Todd JK, Fishalt M, Kapral F, Welch T. Toxic shock syndrome associated with phage group 1 staphylococci. Lancet 1978; ii:1116-18.
2. Todd JK, Franco-Buff AM, Lawellin DW, Vasil ML. Phenotypic distinctivencss of S. aureus strains associated with toxic shock syndrome. Infect Immun 1984; 45:339-44.
3. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndrome Staphylococcus aureus isolates. Lancet 1981; i:1017-21.
4. Schlievert PM, Shands KM, Dan BB, Schmid GP, Nishimura RD. Identification and characterisation of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J Infect Dis 1981; 143:509-16.
5. Bonventre PF, Weckbach L, Staneck J, Schlievert PM, Thompson M. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by S. aureus isolates from toxic shock syndrome associated sources. Infect Immun 1983; 40:1023-9.
6. Reiser RF, Robbins RN, Khoe GP, Bergdoll MS. Purification and some physicochcmical properties of toxic shock toxin. Biochcmistry 1983; 22:3907-12.
7. Bergdoll MS, Schlievert PM. Toxic shock syndrome toxin. Lancet 1984;ii:691.
8. Davis JP, Chesney PJ, Wand PJ et al. Toxic shock syndrome: epidemiological features, recurrence risk factors and prevention. New Engl J Med 1980; 303:1429-35.
9. Chesney PJ, Davis JP, Purdy WK, Wand PJ, Chesney RW. Clinical manifestations of toxic shock syndrome. JAMA 1981; 246:741-8.
10. Schrock CG. Disease alert. JAMA 1980; 243:1231.
11. Lanes SF, Rothman KJ. Tampon absorbency, composition and oxygen content and risk of toxic shock syndrome. J Clin Epidemiol 1990; 43:1379-85.
12. Lee AC, Crass BA, Bergdoll MS. Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin-1 by S. aureus. J Clin Microbiol 1987; 25:87-90.
13. Schuchat A, Broome CV. Toxic shock syndrome and tampons. Epidemiol Rev 1991; 13:99-112.
14. Todd JK, Todd H, Franco-Buff A, Smith CM, Lawellin DW. Influence of focal growth conditions on the pathogenesis of toxic shock syndrome. J Infect Dis 1987; 155:673-81.
15. Marples RR, Weineke AA. Toxic shock syndrome and related conditions in the United Kingdom 1992-1993. Communic Dis Rep 1994; 4:R1.
16. Reingold AL, Hargrett NT, Dan DB, Shands KN, Strickland BY, Broome CV. Non-menstrual toxic shock syndrome. A review of 130 cases. Ann Int Med 1982; 96:871-4.
17. Gahrn-Hansen B, Lundicvist L, Nielson E. Pyomyositis and probable toxic shock syndrome caused by a toxin-1-producing strain of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1989; 8:89-90.
18. Allen ST, Liland JB, Nichols CG, Glew RH. Toxic shock syndrome associated with the use of nasal packing. Arch Intern Med 1990; 150:2587-8.